UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

Movement disorders, 2016-08, Vol.31 (8), p.1203-1208

2016

Volltextzugriff (PDF)

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Neurology, 2010-05, Vol.74 (19), p.1531-1537

2010

Volltextzugriff (PDF)

Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience

European radiology, 2022-02, Vol.32 (2), p.1127-1134

2022

Volltextzugriff (PDF)

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Neurology, 2005-12, Vol.65 (12), p.1863-1872

2005

Volltextzugriff (PDF)

Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment

The Gerontologist, 2011-02, Vol.51 (1), p.17-27

2011

Volltextzugriff (PDF)

Factors that affect lifespan in mild versus moderate Alzheimer's disease

Neurobiology of aging, 2014-03, Vol.35, p.S25-S25

2014

Volltextzugriff (PDF)

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

International journal of geriatric psychiatry, 2011-01, Vol.26 (1), p.100-105

2011

Volltextzugriff (PDF)

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies

Neurology, 2007-10, Vol.69 (16), p.1569-1579

2007

Volltextzugriff (PDF)

Lack of orthostatic symptoms in dementia patients with orthostatic hypotension

Clinical autonomic research, 2015-04, Vol.25 (2), p.87-94

2015

Volltextzugriff (PDF)

Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity

International psychogeriatrics, 2009-04, Vol.21 (2), p.216-219

2009

Volltextzugriff (PDF)

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

International journal of geriatric psychiatry, 2011-02, Vol.26 (2), p.206-213

2011

Volltextzugriff (PDF)

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls

Dementia and geriatric cognitive disorders, 2008-01, Vol.26 (3), p.284-290

2008

Volltextzugriff (PDF)

Usefulness of Computed Tomography Linear Measurements in Diagnosing Alzheimer's Disease

Acta radiologica (1987), 2008-02, Vol.49 (1), p.91-97

2008

Volltextzugriff (PDF)

The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies

International journal of geriatric psychiatry, 2008-02, Vol.23 (2), p.192-198

2008

Volltextzugriff (PDF)

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting

Dementia and geriatric cognitive disorders, 2007-01, Vol.23 (3), p.150-160

2007

Volltextzugriff (PDF)

Pathogenesis of Autoimmune Diseases: Antibodies Against Transglutaminase, Peptidylarginine Deiminase and Protein-bound Citrulline in Primary Sjögren's Syndrome, Multiple Sclerosis and Alzheimer's Disease

Scandinavian journal of immunology, 2008-06, Vol.67 (6), p.626-631

2008

Volltextzugriff (PDF)

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia

PloS one, 2012-10, Vol.7 (10), p.e45451-e45451

2012

Volltextzugriff (PDF)

Effects of a goal-oriented rehabilitation program in mild cognitive impairment: a pilot study

American journal of Alzheimer's disease and other dementias, 2008-04, Vol.23 (2), p.177-183

2008

Volltextzugriff (PDF)

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

International journal of geriatric psychiatry, 2009-06, Vol.24 (6), p.638-647

2009

Volltextzugriff (PDF)

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Lancet neurology, 2006-03, Vol.5 (3), p.228-234

2006

Volltextzugriff (PDF)

Diagnostic Accuracy of the Swedish Version of the Multicultural Cognitive Examination for Cognitive Assessment in Swedish Memory Clinics

Journal of Alzheimer's disease, 2024-01, Vol.97 (2), p.715-726

2024

Volltextzugriff (PDF)

Exploring the prevalence of undetected bradyarrhythmia in dementia with Lewy bodies

Clinical autonomic research, 2023-08, Vol.33 (4), p.433-442

2023

Volltextzugriff (PDF)

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

Lancet neurology, 2009-07, Vol.8 (7), p.613-618

2009

Volltextzugriff (PDF)

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

Journal of Alzheimer's disease, 2016-08, Vol.54 (1), p.287-295

2016

Volltextzugriff (PDF)

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease

Dementia and geriatric cognitive disorders, 2008-01, Vol.25 (6), p.508-515

2008

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(171)
Tagungsberichte
(20)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

CSF biomarkers predict a more malignant outcome in Alzheimer disease

Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment

Factors that affect lifespan in mild versus moderate Alzheimer's disease

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies

Lack of orthostatic symptoms in dementia patients with orthostatic hypotension

Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls

Usefulness of Computed Tomography Linear Measurements in Diagnosing Alzheimer's Disease

The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting

Pathogenesis of Autoimmune Diseases: Antibodies Against Transglutaminase, Peptidylarginine Deiminase and Protein-bound Citrulline in Primary Sjögren's Syndrome, Multiple Sclerosis and Alzheimer's Disease

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia

Effects of a goal-oriented rehabilitation program in mild cognitive impairment: a pilot study

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Diagnostic Accuracy of the Swedish Version of the Multicultural Cognitive Examination for Cognitive Assessment in Swedish Memory Clinics

Exploring the prevalence of undetected bradyarrhythmia in dementia with Lewy bodies

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease

Suchergebnisse filtern